William M. Byra

763 total citations
16 papers, 510 citations indexed

About

William M. Byra is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, William M. Byra has authored 16 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 2 papers in Internal Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in William M. Byra's work include Atrial Fibrillation Management and Outcomes (9 papers), Heart Failure Treatment and Management (7 papers) and Cardiovascular Function and Risk Factors (3 papers). William M. Byra is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Heart Failure Treatment and Management (7 papers) and Cardiovascular Function and Risk Factors (3 papers). William M. Byra collaborates with scholars based in United States, United Kingdom and Netherlands. William M. Byra's co-authors include Mandeep R. Mehra, Barry Greenberg, John G.F. Cleland, Faı̈ez Zannad, Stefan D. Anker, Min Fu, Theodore E. Spiro, Dirk J. van Veldhuisen, Mihai Gheorghiade and James D. Neaton and has published in prestigious journals such as New England Journal of Medicine, Circulation and Scientific Reports.

In The Last Decade

William M. Byra

16 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William M. Byra United States 9 430 94 57 57 49 16 510
Robert Edfors Sweden 10 301 0.7× 71 0.8× 54 0.9× 39 0.7× 55 1.1× 20 422
Damirbek Osmonov Türkiye 14 270 0.6× 32 0.3× 95 1.7× 72 1.3× 45 0.9× 35 445
Kwang‐No Lee South Korea 15 632 1.5× 56 0.6× 57 1.0× 76 1.3× 71 1.4× 53 759
Michael Schmohl Germany 11 563 1.3× 400 4.3× 73 1.3× 67 1.2× 15 0.3× 18 710
Jonathan Piccini United States 10 651 1.5× 96 1.0× 48 0.8× 46 0.8× 34 0.7× 17 712
Sefa Ünal Türkiye 10 174 0.4× 39 0.4× 49 0.9× 67 1.2× 34 0.7× 34 337
Jen‐Te Hsu Taiwan 13 179 0.4× 25 0.3× 111 1.9× 29 0.5× 38 0.8× 34 343
Barış Şimşek Türkiye 10 217 0.5× 40 0.4× 47 0.8× 37 0.6× 115 2.3× 34 295
Mustafa Soylu Türkiye 11 261 0.6× 49 0.5× 67 1.2× 31 0.5× 34 0.7× 38 363
Nina Ghosh Canada 12 247 0.6× 67 0.7× 65 1.1× 44 0.8× 64 1.3× 26 366

Countries citing papers authored by William M. Byra

Since Specialization
Citations

This map shows the geographic impact of William M. Byra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Byra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Byra more than expected).

Fields of papers citing papers by William M. Byra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Byra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Byra. The network helps show where William M. Byra may publish in the future.

Co-authorship network of co-authors of William M. Byra

This figure shows the co-authorship network connecting the top 25 collaborators of William M. Byra. A scholar is included among the top collaborators of William M. Byra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. Byra. William M. Byra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Girerd, Nicolas, John G.F. Cleland, Stefan D. Anker, et al.. (2022). Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Scientific Reports. 12(1). 8574–8574. 20 indexed citations
2.
Ferreira, João Pedro, John G.F. Cleland, Carolyn S.P. Lam, et al.. (2021). Impact of Geographic Region on the COMMANDER-HF Trial. JACC Heart Failure. 9(3). 201–211. 7 indexed citations
3.
Ferreira, João Pedro, John G.F. Cleland, Carolyn S.P. Lam, et al.. (2021). New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clinical Research in Cardiology. 111(1). 50–59. 5 indexed citations
4.
Ferreira, João Pedro, John G.F. Cleland, Carolyn S.P. Lam, et al.. (2021). Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE. Clinical Research in Cardiology. 110(10). 1554–1563. 4 indexed citations
5.
Ferreira, João Pedro, Carolyn S.P. Lam, Stefan D. Anker, et al.. (2020). Plasma D ‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial. European Journal of Heart Failure. 23(4). 648–656. 12 indexed citations
6.
Cunningham, Jonathan W., João Pedro Ferreira, Hsiaowei Deng, et al.. (2020). Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial. JACC Heart Failure. 8(5). 359–368. 10 indexed citations
7.
Mehra, Mandeep R., Muthiah Vaduganathan, Min Fu, et al.. (2019). A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. European Heart Journal. 40(44). 3593–3602. 61 indexed citations
8.
Greenberg, Barry, James D. Neaton, Stefan D. Anker, et al.. (2019). Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm. JAMA Cardiology. 4(6). 515–515. 44 indexed citations
9.
Greenberg, Barry, Stefan D. Anker, William M. Byra, et al.. (2018). Effects of Rivaroxaban on Thrombotic Events in Heart Failure Patients With Coronary Disease and Sinus Rhythm. Circulation. 138(25). 1 indexed citations
10.
Zannad, Faı̈ez, Stefan D. Anker, William M. Byra, et al.. (2018). Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease. New England Journal of Medicine. 379(14). 1332–1342. 222 indexed citations
11.
Greenberg, Barry, Stefan D. Anker, William M. Byra, et al.. (2018). A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study. Journal of Cardiac Failure. 24(11). 811–811. 1 indexed citations
12.
13.
Moore, Kenneth Todd, et al.. (2014). Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects. British Journal of Clinical Pharmacology. 79(6). 907–917. 6 indexed citations
14.
Moreyra, Abel E., et al.. (1986). Nondominant right coronary artery occlusion presenting with isolated right ventricular infarction and ventricular fibrillation. The American Journal of Medicine. 81(1). 146–148. 23 indexed citations
15.
Gary, Nancy E., William M. Byra, & Robert P. Eisinger. (1981). Carbamazepine Poisoning: Treatment by Hemoperfusion. ˜The œNephron journals/Nephron journals. 27(4-5). 202–203. 29 indexed citations
16.
Stevenson, Nancy R., et al.. (1977). Lack of circadian rhythmicity of rat fetal intestinal enzymes as compared to the dams. Developmental Biology. 60(2). 487–492. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Edfors Breakdown of academic impact, for papers by Damirbek Osmonov Breakdown of academic impact, for papers by Kwang‐No Lee Breakdown of academic impact, for papers by Michael Schmohl Breakdown of academic impact, for papers by Jonathan Piccini Breakdown of academic impact, for papers by Sefa Ünal Breakdown of academic impact, for papers by Jen‐Te Hsu Breakdown of academic impact, for papers by Barış Şimşek Breakdown of academic impact, for papers by Mustafa Soylu Breakdown of academic impact, for papers by Nina Ghosh
Rankless by CCL
2026